RVPH: CVI Investments reports 4.9% position
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Reviva Pharmaceuticals Holdings, Inc. is the subject of a Schedule 13G/A reporting that CVI Investments, Inc. and Heights Capital Management, Inc. collectively hold 672,811 shares of common stock, representing 4.9% of the class. The filing states these shares "consist of Shares issuable upon the exercise of warrants" and that the warrants are restricted so exercises cannot cause ownership to exceed 4.99%. The company reported 12,810,377 Shares outstanding as of March 27, 2026. The filing is signed on 05/13/2026.
Insights
Reporting shows a sub-5% position held via warrants and shared voting control.
The filing lists 672,811 shares as beneficially owned, equal to 4.9% of the outstanding common stock (March 27, 2026 outstanding: 12,810,377 shares). The filing explicitly states these holdings "consist of Shares issuable upon the exercise of warrants," and that exercises are limited to prevent exceeding 4.99%.
Heights Capital Management, Inc. is disclosed as an investment manager with shared voting and dispositive power over the reported shares; the text also contains a disclaimer of beneficial ownership except for pecuniary interest. Future filings would show any changes in exercised warrants or voting arrangements.
Position is an issuer-side disclosure of potential overhang but stays below the 5% reporting threshold.
The filing clarifies the shares reported arise from warrants and that the warrants contain an ownership cap tied to 4.99%, limiting immediate dilution risk captured here. The document ties the position scale to the exact outstanding share count as of March 27, 2026.
As a factual matter, cash‑flow treatment or planned exercises are not stated. Subsequent amendments or Form 4/Form 5 filings would record any actual exercises or transfers.
Key Figures
Key Terms
beneficially owned regulatory
warrants financial
Section 13(d) regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake do CVI Investments and Heights Capital report in Reviva (RVPH)?
Who signs the Schedule 13G/A on behalf of the reporting entities for RVPH?
AI-generated analysis. How Rhea-AI works. Not financial advice.